| Hazard Information | Back Directory | [Uses]
SGC agonist 2 is a potent agonist of soluble guanylate cyclase (SGC). Soluble guanylate cyclase is a key signal transduction enzyme in the NO-sGC-cGMP signaling pathway. SGC agonist 2 has the potential for the research of cardiovascular disease (heart failure, pulmonary hypertension, angina, myocardial infarction) and fibrotic diseases (renal fibrosis, systemic sclerosis) (extracted from patent WO2021219088A1, compound 031)[1]. | [References]
[1] Fuyu Luo, et al. Pyrimidine tricyclic compounds and their applications. Patent WO2021219088A1. |
|
|